[Post-transplant lymphoproliferative disorders following allogenic bone marrow transplantation].
Zhang
Shu-hong
SH
Zhou
Xiao-ge
XG
Yu
Xiao-meng
XM
Wang
Chao
C
Huang
Shou-fang
SF
D000328:Adult; D018951:Antigens, CD20 / Q000378:metabolism; D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D017252:CD3 Complex / Q000378:metabolism; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D017245:Foscarnet / Q000627:therapeutic use; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000821:virology; D008297:Male
D018951:Antigens, CD20; D000998:Antiviral Agents; D017252:CD3 Complex; D019394:Ki-67 Antigen; D017245:Foscarnet